NASDAQ:ISPC iSpecimen Q2 2025 Earnings Report $1.26 +0.01 (+0.80%) Closing price 09/25/2026 04:00 PM EasternExtended Trading$1.22 -0.04 (-3.10%) As of 09/25/2026 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. ProfileEarnings HistoryForecast iSpecimen EPS ResultsActual EPS-$16.80Consensus EPS -$152.00Beat/MissBeat by +$135.20One Year Ago EPSN/AiSpecimen Revenue ResultsActual Revenue$0.71 millionExpected Revenue$3.10 millionBeat/MissMissed by -$2.39 millionYoY Revenue GrowthN/AiSpecimen Announcement DetailsQuarterQ2 2025Date8/14/2025TimeBefore Market OpensConference Call DateThursday, August 14, 2025Conference Call Time7:00AM ETUpcoming EarningsiSpecimen's Q3 2026 earnings is estimated for Thursday, November 5, 2026, based on past reporting schedulesConference Call ResourcesQuarterly Report (10-Q)Earnings HistoryCompany ProfilePowered by Earnings DocumentsQuarterly report(10-Q) iSpecimen Earnings HeadlinesReviewing VivoSim Labs (NASDAQ:VIVS) and iSpecimen (NASDAQ:ISPC)September 26 at 5:29 AM | americanbankingnews.comISpecimen In Focus, Genelux Nears Phase 3 Ovarian Cancer Data, Biofrontera Awaits FDA DecisionSeptember 8, 2026 | rttnews.comA letter from Shannon StansberryPorter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down year in nearly two decades and total gains of almost 2,000% - his immediate reaction was disbelief. It took a trusted friend's personal vouching for Emmet Savage and a face-to-face trip to Ireland to change his mind. The full documentary, Investigating Project Prophet, is now live.September 26 at 1:00 AM | Porter & Company (Ad)iSpecimen to Acquire Foldlab AI Disease AnalyticsSeptember 4, 2026 | tipranks.comiSpecimen Completes Large-Scale International Cancer Research Order; Samples Shipped Within Three WeeksAugust 20, 2026 | globenewswire.comiSpecimen Engages IR Agency for Investor MarketingAugust 14, 2026 | tipranks.comSee More iSpecimen Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like iSpecimen? Sign up for Earnings360's daily newsletter to receive timely earnings updates on iSpecimen and other key companies, straight to your email. Email Address About iSpecimeniSpecimen (NASDAQ:ISPC), Inc. operates a digital marketplace designed to connect life sciences researchers with human biospecimens and related clinical information. Its platform helps researchers identify and request samples such as blood, tissue, and other biological materials from hospitals, laboratories, biobanks, and other healthcare or research organizations. The company’s services support biospecimen sourcing, patient and donor matching, inventory discovery, order management, and sample logistics. iSpecimen serves pharmaceutical and biotechnology companies, diagnostic developers, academic institutions, and other organizations conducting biomedical research and developing new therapies and tests. Founded in 2009, iSpecimen has focused on using software to streamline access to traditionally fragmented biospecimen inventories. Its marketplace is intended to support research across multiple disease areas and geographic regions, subject to the availability of participating providers and applicable regulatory and privacy requirements.View iSpecimen ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles MarketBeat Week in Review – 09/21 - 09/25Costco Ends Its Fiscal Year on a High Note, Eyes Big ExpansionCracker Barrel Stock Is Rallying Again, But the Turnaround Still Has a Traffic ProblemDarden Restaurants Serves Up Fresh Catalysts for a Stock Price RallySoFi Is Bypassing the Banking Bottleneck With Stablecoin SettlementSuper Micro’s Vera Rubin Shipments Put Its AI Infrastructure Advantage to the TestHims & Hers Slides Nearly 7% as Legal Pressure Adds to Its Growing List of Risks Upcoming Earnings Micron Technology (9/30/2026)NIKE (10/1/2026)Accenture (10/1/2026)PepsiCo (10/8/2026)Delta Air Lines (10/9/2026)America Movil (10/13/2026)BlackRock (10/13/2026)Citigroup (10/13/2026)The Goldman Sachs Group (10/13/2026)JPMorgan Chase & Co. (10/13/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
